Stents Drug Eluting

Gore, Tigris stent, fluoropolymer nitinol stent, peripheral artery disease

The Gore Tigris is a dual-component stent with a unique fluoropolymer / nitinol design.

Technology | Stents Peripheral | August 02, 2016

August 2, 2016 —The U.S. Food and Drug Administration (FDA) granted market clearance for W. L. Gore & Associates...

Biotronik, ORIENT trial results, EuroPCR 2016, Orsiro DES, hybrid drug-eluting stent
News | Stents Drug Eluting | June 03, 2016

June 3, 2016 — Biotronik announced results establishing non-inferiority of the Orsiro hybrid...

Biosensors' Biomatrix stent.

Feature | Stents | May 16, 2016

May 16, 2016 — Cardinal Health announced it has entered into a distribution agreement with Biosensors that enables...

Medtronic, Drug-Filled Stent, RevElution Trial results, ACC.16, CE Mark
News | Stents Drug Eluting | April 21, 2016

April 21, 2016 — Medtronic plc announced new clinical data from one of the endpoints in the RevElution Trial for its...

Absorb, bioresorbable stents
Feature | Stents Bioresorbable | April 13, 2016 | Dave Fornell

Bioresorbable stents have been one of the hottest new cardiovascular technologies discussed at cardiology meetings...

Biotronik, BIOSCIENCE trial, Orsiro hybrid DES, drug-eluting stent, STEMI heart attack patients
News | Stents Drug Eluting | March 07, 2016

March 7, 2016 — Biotronik announced publication of results from the...

Medtronic, CE Mark, Resolute Onyx DES, drug-eluting stent, expanded sizes and indications
News | Stents Drug Eluting | February 02, 2016

February 2, 2016 — Medtronic plc announced the recent CE Mark and commercial launch for an expanded size matrix of...

News | Stents Drug Eluting | January 08, 2016

January 8, 2016 — In December, Stentys announced completion of patient enrollment in DESSOLVE III. The 1,400-patient...

Blog | Cath Lab | November 05, 2015

For the past few years, the focus of the annual Transcatheter Cardiovascular Therapeutics (TCT) meetings has been on...

Videos | TCT | November 05, 2015

DAIC Editor Dave Fornell offers his choices for the most innovative new interventional cardiovascular technologies...

Videos | TCT | November 05, 2015

Tom Watson, clinical analyst for MDBuyLine, and DAIC Dave Fornell discuss some of the technology trends at the 2015...

News | Stents Bioresorbable | October 30, 2015

October 30, 2015 — Results from a clinical trial showed that that the Abbott Absorb everolimus-eluting bioresorbable...

Videos | Stents Drug Eluting | October 30, 2015

Dr. Stephen Worthley, Ph.D., director of the cardiac cath labs at Royal Adelaide Hospital at the University of...

Videos | Stents Bioresorbable | October 30, 2015

Dean Kereiakes, M.D., medical director of The Christ Hospital Heart and Vascular Center, and a lead investigator for...

News | Stents Drug Eluting | October 27, 2015

October 27, 2015 — Results from the multicenter, prospective, randomized PANDA III trial indicate that the BuMA...

Overlay Init